The aging population of the United States creates pharmaceutical challenges for the practicing emergency physician. Polypharmacy, drug-drug and drug-disease interactions, and other pharmaceutical complications from the pathophysiologic changes associated with aging need to be recognized in order to optimize outcomes in the elderly. Effective strategies that improve patients outcomes include a better understanding of the physiologic and pharmacologic changes that occur with aging, integrated use of clinical emergency department pharmacists, and choosing nonpharmacologic treatment options when possible.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2afml5Q
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose The aim of the study was to identify the incidence of new sexual dysfunction reported by the patient in surgical treatmen...
-
Author Correction: Drier Climatic Conditions Increase Withanolide Content of Withania coagulans Enhancing its Inhibitory Potential against H...
-
https://ift.tt/2EnPwWR
-
Do you have one protocol for incoming STEMI patients from EMS? Another one for in-hospital? What about a patient who’s being transferred? In...
-
Journal of Occupational Medicine and Toxicology from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2s47nvW
-
from EMS via xlomafota13 on Inoreader http://ift.tt/2lYl8cK
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου